A Seattle life science redevelopment project has landed an anchor tenant to take nearly a third of its space in a sign of strength for the region's biotech market even as national indicators have become mixed.
Seattle Life Science Redevelopment Lands Anchor Tenant
Sonoma Biotherapeutics To Take Nearly a Third of Unison Elliott Bay Project
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In